- Home
- FDUS vs CRMD Comparison
FDUS vs CRMD Comparison
Compare FDUS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDUS
- CRMD
- Stock Information
- Founded
- FDUS 2011
- CRMD 2006
- Country
- FDUS United States
- CRMD United States
- Employees
- FDUS N/A
- CRMD N/A
- Industry
- FDUS Finance/Investors Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- FDUS Finance
- CRMD Health Care
- Exchange
- FDUS Nasdaq
- CRMD Nasdaq
- Market Cap
- FDUS 759.3M
- CRMD 645.0M
- IPO Year
- FDUS 2011
- CRMD 2010
- Fundamental
- Price
- FDUS $23.06
- CRMD $10.13
- Analyst Decision
- FDUS
- CRMD Strong Buy
- Analyst Count
- FDUS 0
- CRMD 6
- Target Price
- FDUS N/A
- CRMD $15.67
- AVG Volume (30 Days)
- FDUS 146.6K
- CRMD 891.8K
- Earning Date
- FDUS 03-03-2025
- CRMD 03-11-2025
- Dividend Yield
- FDUS 10.02%
- CRMD N/A
- EPS Growth
- FDUS 26.64
- CRMD N/A
- EPS
- FDUS 2.78
- CRMD N/A
- Revenue
- FDUS $145,008,000.00
- CRMD $12,262,234.00
- Revenue This Year
- FDUS $13.81
- CRMD N/A
- Revenue Next Year
- FDUS $0.02
- CRMD $234.92
- P/E Ratio
- FDUS $8.30
- CRMD N/A
- Revenue Growth
- FDUS 19.57
- CRMD 41184.20
- 52 Week Low
- FDUS $18.41
- CRMD $3.03
- 52 Week High
- FDUS $23.55
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- FDUS 66.32
- CRMD 44.90
- Support Level
- FDUS $22.28
- CRMD $9.79
- Resistance Level
- FDUS $23.55
- CRMD $11.28
- Average True Range (ATR)
- FDUS 0.26
- CRMD 0.51
- MACD
- FDUS 0.00
- CRMD -0.05
- Stochastic Oscillator
- FDUS 61.42
- CRMD 23.84
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.